14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial. [electronic resource]
Producer: 20191008Description: 2510-2518 p. digitalISSN:- 1460-2091
- Adult
- Aged
- Aged, 80 and over
- Antacids -- administration & dosage
- Anti-Bacterial Agents -- administration & dosage
- Anti-Ulcer Agents -- administration & dosage
- Bismuth -- administration & dosage
- Drug Therapy, Combination -- adverse effects
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Esomeprazole -- administration & dosage
- Helicobacter Infections -- drug therapy
- Helicobacter pylori -- isolation & purification
- Humans
- Middle Aged
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.